Published in Cancer J on July 21, 2017
Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83
Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med (2012) 13.49
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet (2002) 13.16
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet (2014) 11.01
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Overdiagnosis in cancer. J Natl Cancer Inst (2010) 10.31
Cancer screening in elderly patients: a framework for individualized decision making. JAMA (2001) 9.79
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med (2014) 7.39
Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med (2013) 7.19
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst (2009) 6.96
Development and validation of a prognostic index for 4-year mortality in older adults. JAMA (2006) 6.79
Screening for colorectal cancer: recommendation and rationale. Ann Intern Med (2002) 6.56
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 6.26
Long-term mortality after screening for colorectal cancer. N Engl J Med (2013) 5.81
PSA screening among elderly men with limited life expectancies. JAMA (2006) 5.70
Complications after prostate biopsy: data from SEER-Medicare. J Urol (2011) 5.40
Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep (2012) 5.12
Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol (2010) 4.84
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ (2012) 4.64
Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med (2012) 4.47
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med (2013) 4.09
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA (2016) 4.06
Systematic review of complications of prostate biopsy. Eur Urol (2013) 3.66
A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA (2014) 3.58
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med (2011) 3.38
Epidemiology of lung cancer. Chest (2003) 3.35
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med (2012) 3.27
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2016) 3.02
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA (2016) 3.00
Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol (2010) 2.89
Model of outcomes of screening mammography: information to support informed choices. BMJ (2005) 2.86
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med (2014) 2.70
Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology (2004) 2.63
Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst (2010) 2.50
Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol (2010) 2.45
Incorporating lag time to benefit into prevention decisions for older adults. JAMA (2013) 2.40
Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med (2013) 2.38
Reevaluating PSA Testing Rates in the PLCO Trial. N Engl J Med (2016) 2.29
STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg (2010) 2.25
American Geriatrics Society identifies another five things that healthcare providers and patients should question. J Am Geriatr Soc (2014) 2.23
External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc (2011) 2.20
Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med (2009) 2.15
Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol (2004) 2.14
Older adults and forgoing cancer screening: "I think it would be strange". JAMA Intern Med (2013) 2.08
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. J Clin Oncol (2015) 1.95
Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med (2002) 1.82
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut (2007) 1.79
The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer (2013) 1.76
Screening mammography in older women: a review. JAMA (2014) 1.70
Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc (2000) 1.70
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut (2011) 1.67
The Thoracic Surgery Scoring System (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg (2007) 1.66
Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology (2005) 1.65
Prostate-specific antigen: current status. CA Cancer J Clin (2001) 1.63
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. JAMA (2016) 1.56
Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. J Natl Cancer Inst (2015) 1.56
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med (2014) 1.56
Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatr (2006) 1.53
Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med (2005) 1.49
Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent. Cancer (2004) 1.48
American Urological Association (AUA) guideline on prostate cancer detection: process and rationale. BJU Int (2013) 1.41
Cognitive impairment: an independent predictor of excess mortality: a cohort study. Ann Intern Med (2011) 1.39
High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol (2013) 1.31
Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med (2014) 1.18
Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc (2013) 1.17
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med (2015) 1.17
Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology (2002) 1.14
A targeted decision aid for the elderly to decide whether to undergo colorectal cancer screening: development and results of an uncontrolled trial. BMC Med Inform Decis Mak (2010) 1.02
Plans to stop cancer screening tests among adults who recently considered screening. J Gen Intern Med (2010) 1.01
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer (2014) 1.00
Older women's experience with a benign breast biopsy—a mixed methods study. J Gen Intern Med (2014) 1.00
Weighing the benefits and burdens of mammography screening among women age 80 years or older. J Clin Oncol (2009) 0.97
Screening in frail older people: an ounce of prevention or a pound of trouble? J Am Geriatr Soc (2010) 0.92
Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prev Med (2014) 0.90
Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy. Clin Geriatr Med (2015) 0.88
Individualizing cancer screening in older adults: a narrative review and framework for future research. J Gen Intern Med (2012) 0.86
Prognostic indices for older adults: a systematic review. JAMA (2012) 5.70
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol (2011) 2.51
Am I doing the right thing? Provider perspectives on improving palliative care in the emergency department. Ann Emerg Med (2008) 1.56
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer (2014) 1.00
Emergency department experiences of acutely symptomatic patients with terminal illness and their family caregivers. J Pain Symptom Manage (2010) 0.96
Mammography screening among women age 80 years and older: consider the risks. J Clin Oncol (2008) 0.94
Elements of a high-quality inpatient consultation in the intensive care unit. A qualitative study. Ann Am Thorac Soc (2013) 0.88
Usefulness and effect of online prognostic calculators. J Am Geriatr Soc (2014) 0.80
Should We Offer Medication to Reduce Breast Cancer Risk?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med (2016) 0.75